27.09USD-2.45%Mkt Cap: 1.88B $P/E: —1d ago
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a prote…
Indicators:|
Key Statistics
Company
Market Cap1.88B $
Enterprise Value2.15B $
Revenue (TTM)87.16M $
Gross Profit41.70M $
Net Income (TTM)-29.82M $
Revenue/Share7.387 USD
Last Price27.09 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees222
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-38.50
PEG—
EV/EBITDA-67.12
EV/Revenue24.71
P/S21.54
P/B-10.54
EPS (TTM)-0.65
EPS (Forward)-0.70
52W Range
18.8484% of range28.68
52W High28.68 USD
52W Low18.84 USD
Profitability
Gross Margin56.20%
Oper. Margin-47.42%
EBITDA Margin-36.81%
Profit Margin-40.18%
ROE18.76%
ROA-21.30%
Growth
Revenue Growth98.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-53.61M $
CapEx (TTM)6.38M $
FCF Margin—
FCF Yield—
Net Debt40.96M $
Net Debt/EBITDA-1.28
Balance Sheet
Debt/Equity-0.26
Current Ratio5.88
Quick Ratio3.50
Book Value/Sh-2.5690 USD
Cash/Share0.9320 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)30.00 USD
Upside (mean)+10.7%
Target Range27.00 USD – 35.00 USD
$27.00+10.7% to mean$35.00
# Analysts5
Ownership
Shares Out.69.31M
Float36.38M
Insiders26.67%
Institutions29.10%
Short Interest
Short Ratio8.9d
Short % Float4.39%
Short % Out.2.71%
Shares Short1.88M
Short (prev mo.)1.70M
Technical
SMA 5022.54 (+20.2%)
SMA 20022.54 (+20.2%)
Beta—
S&P 52W Chg20.05%
Avg Vol (30d)284.29K
Avg Vol (10d)552.61K
Technical Indicators
RSI (14)68.5
MACD1.3468
MACD Signal0.5657
MACD Hist.+0.7811
BB Upper27.71 USD
BB Middle22.50 USD
BB Lower17.28 USD
BB Width46.39%
ATR (14)1.753 USD
Vol Ratio (20d)1.14x